Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to ...
Zydus, a leading, discovery-based, global lifesciences company, announces the launch of ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback